IntroductionBiochemical markers of myocardial injury are frequently altered after cardiac
surgery. So far there is no evidence whether oral beta-blockers may reduce
myocardial injury after coronary artery bypass grafting. ObjectiveTo determine if oral administration of prophylactic metoprolol reduces the release
of cardiac troponin I in isolated coronary artery bypass grafting, not complicated
by new Q waves. MethodsA prospective randomized study, including 68 patients, divided in 2 groups: Group
A (n=33, control) and B (n=35, beta-blockers). In group B, metoprolol tartrate was
administered 200 mg/day. The myocardial injury was assessed by troponin I with 1
hour and 12 hours after coronary artery bypass grafting. ResultsNo significant difference between groups regarding pre-surgical, surgical,
complication in intensive care (15% versus 14%,
P=0.92) and the total number of hospital events (21%
versus 14%, P=0.45) was observed. The median
value of troponin I with 12 hours in the study population was 3.3 ng/ml and was
lower in group B than in group A (2.5 ng/ml versus 3.7 ng/ml,
P<0,05). In the multivariate analysis, the variables that
have shown to be independent predictors of troponin I release after 12 hours were:
no beta-blockers administration and number of vessels treated. ConclusionThe results of this study in uncomplicated coronary artery bypass grafting,
comparing the postoperative release of troponin I at 12 hours between the control
group and who used oral prophylactic metoprolol for at least 72 hours, allow to
conclude that there was less myocardial injury in the betablocker group, giving
some degree of myocardial protection.
Age, poor medical history, cardiac arrest, use of vasopressors, and hemodynamic instability were the most prevalent reasons for refusal of donor hearts. Echocardiogram evaluation is a potential intervention to improve heart transplantation conversion in Brazil.
Objective:To define donors' profile of an Organ and Tissue Procurement Center and compare the family consent for tissue donation before and after modification of the Donation Term.Methods:A descriptive, documentary and quantitative study performed in an Organ and Tissue Procurement Center, analyzed 111 feasible donors' charts in the period from March 13 to September 13, 2010 (1st period), and from September 14, 2010 to March 14, 2011 (2nd period), based on the modification date.Results:The mean age of donors was 45.2 years, being 52.3% female. The causes of death included cerebral vascular accident (stroke) (64%), head trauma (27%), anoxic encephalopathy (2.7%), firearm injuries (2.7%) and others (3.6%). The notifications were predominantly of spontaneous origin (91%). Comparing the periods before and after the modification of the Donation Term, the donation consent for cornea increased by 17.2% and the consent for skin, bones, tendons and muscles had a discreet increase by 3.1%, 9.9% and 0.4%, respectively. On the other hand, there was decrease in consent for blood vessel (0.8%) and heart valves (4.1%) between the two periods.Conclusion:There was increase in family consent for donation of most tissues, but it was statistically significant only for cornea donation.
Left ventricular noncompaction is a rare congenital anomaly characterized by excessive left ventricular trabeculation, deep intertrabecular recesses and a thin compacted layer due to the arrest of compaction of myocardial fibers during embryonic development. We report the case of a young patient with isolated left ventricular noncompaction, leading to refractory heart failure that required extracorporeal membrane oxygenation followed by emergency heart transplantation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.